Meritrosp. z o.o.Status: Entity active
Research and experimental development on biotechnology
KRS: 0001107511 NIP: 9462740799 REGON: 52871369400000
Overview
Registry date
2024-05-27
Share capital
$1,350.62
Activity description
Meritro is a company that offers OncoVetCure, a diagnostic platform for personalized veterinary oncology. This platform utilizes ex vivo cell cultures to assess the sensitivity of cancer cells to various drugs, enabling veterinarians to customize cancer treatments for dogs. The service aims to enhance treatment effectiveness and improve the chances of recovery for canine patients.
Registered address
Gospodarcza 26, 20-213 Lublin, Poland
Website
meritro.comWebsite active
Email
[email protected]Email address current
Industry
| Name | Code |
|---|---|
Research and experimental development on biotechnologyPrimary | 72.11.Z |
Other research and experimental development on natural sciences and engineering | 72.19.Z |
Other professional, scientific and technical activities not elsewhere classified | 74.90 |
Other personal service activities not elsewhere classified | 96.09.Z |
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Codagenesp. z o.o. | $12,353.20 | codagene.com | |
| Passio Biomaterialssp. z o.o. | $7,738.99 | passio.pl | |
| Oncotherics PolandS.A. | $7,565.27 | oncotherics.com | |
| Concept Groupsp. z o.o. | $6,674.29 | clinicalconsulting.pl | |
| Aiventrosp. z o.o. | $7,266.35 | aiventro.com | |
| Biosynthesissp. z o.o. | $7,201.70 | biosynthesis.pl | |
| ArthecS.A. | $6,901.53 | arthec.eu | |
| Poltisssp. z o.o. | $5,876.72 | poltiss.com | |
| Surgical Planning Solutionssp. z o.o. | $5,774.66 | kolano.pl | |
| M Microbioticssp. z o.o. | $4,826.77 | vp.pl |
Last updated: 2026-04-10